Granules India gets USFDA tentative nod for generic ADHD treatment tablets
New Delhi: Granules India Ltd on Thursday said its arm Granules Pharmaceuticals, Inc has received tentative approval from the US health regulator for its generic amphetamine extended-release tablets indicated for…
Granules India arm gets 5 USFDA observations for Hyderabad facility
Telangana: Granules India has announced that the U.S. Food and Drug Administration (FDA) has concluded an inspection with five observations at the Hyderabad facility of Granules Life Sciences, a wholly…
Glenmark, Granules, Zydus recall products in US over manufacturing issues: USFDA
Domestic drugmakers Glenmark, Granules India, Sun Pharma, Zydus and Unichem are recalling products in the US market for various manufacturing issues, according to the US Food and Drug Administration (USFDA).…
Granules approval for ADHD drug
Granules India said that its wholly owned foreign subsidiary, Granules Pharmaceuticals has received approval from US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Amphetamine Mixed…








